---
figid: PMC4681826__LRT2015-757694.001
figtitle: Signaling pathways activated by BCR-ABL
organisms:
- NA
pmcid: PMC4681826
filename: LRT2015-757694.001.jpg
figlink: /pmc/articles/PMC4681826/figure/fig1/
number: F1
caption: Signaling pathways activated by BCR-ABL. (a) BCR-ABL activates GRB-2/SOS
  which in turn activates RAS. Active RAS activates RAF. Active RAF stimulates MEK1,
  which in turn activates ERK1/2. Activation of Ras pathway by BCR-ABL aids CML cells
  proliferation. On the other hand, activated GRB-2/SOS stimulates GAB2 which activates
  PI3-K pathway. (b) BCR-ABL phosphorylates adaptor proteins like CRK and CRKL leading
  to the activation of PI3-K. PI3-K phosphorylates PIP2 to PIP3 which in turn activates
  AKT. AKT inhibits p27 leading to CML cells proliferation. AKT phosphorylates MDM2,
  which in turn inhibit p53. AKT activates NFκB via phosphorylation of IKK and IkBα.
  AKT inhibits p-BAD. Activation of NFκB and inhibition of p53 and BAD by AKT evade
  apoptosis and promote CML cells survival. (c) BCR-ABL phosphorylates STAT5 which
  also aid in evading apoptosis of CML cells. (d) BCR-ABL phosphorylate cytoskeleton
  proteins resulting in increased cellular motility and reduced adhesion to extracellular
  matrix of bone marrow.
papertitle: Hsp90 Inhibitors for the Treatment of Chronic Myeloid Leukemia.
reftext: Kalubai Vari Khajapeer, et al. Leuk Res Treatment. 2015;2015:757694.
year: '2015'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9631593
figid_alias: PMC4681826__F1
figtype: Figure
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
redirect_from: /figures/PMC4681826__F1
ndex: a34a6249-ded6-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4681826__LRT2015-757694.001.html
  '@type': Dataset
  description: Signaling pathways activated by BCR-ABL. (a) BCR-ABL activates GRB-2/SOS
    which in turn activates RAS. Active RAS activates RAF. Active RAF stimulates MEK1,
    which in turn activates ERK1/2. Activation of Ras pathway by BCR-ABL aids CML
    cells proliferation. On the other hand, activated GRB-2/SOS stimulates GAB2 which
    activates PI3-K pathway. (b) BCR-ABL phosphorylates adaptor proteins like CRK
    and CRKL leading to the activation of PI3-K. PI3-K phosphorylates PIP2 to PIP3
    which in turn activates AKT. AKT inhibits p27 leading to CML cells proliferation.
    AKT phosphorylates MDM2, which in turn inhibit p53. AKT activates NFκB via phosphorylation
    of IKK and IkBα. AKT inhibits p-BAD. Activation of NFκB and inhibition of p53
    and BAD by AKT evade apoptosis and promote CML cells survival. (c) BCR-ABL phosphorylates
    STAT5 which also aid in evading apoptosis of CML cells. (d) BCR-ABL phosphorylate
    cytoskeleton proteins resulting in increased cellular motility and reduced adhesion
    to extracellular matrix of bone marrow.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ABL1
  - GRB2
  - CRK
  - CBL
  - CRKL
  - GAB2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K1
  - MAP2K2
  - AKT1
  - AKT2
  - AKT3
  - MDM2
  - MAPK3
  - MAPK1
  - IFI27
  - PSMD9
  - ZNRD2
  - DCTN6
  - TMED7
  - H3P23
  - BAD
  - CHUK
  - IKBKB
  - IKBKG
  - IKBKE
  - TBK1
  - STAT5A
  - STAT5B
  - TP53
  - TP63
  - TP73
  - NFKBIA
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - XYLT2
  - SOS1
  - SOS2
  - drk
  - Crk
  - .na.character
  - Cbl
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - ras
  - Ras64B
  - Ras85D
  - Raf
  - Dsor1
  - Akt
  - rl
  - DCTN6-p27
  - dap
  - CG9588
  - cass
  - IKKepsilon
  - key
  - IKKbeta
  - p53
  - betaTub60D
  - hth
  - Dif
  - dl
  - Rel
  - Sos
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
